Intervention

Albuterol MDPI

ClinicalTrials.gov intervention label

Clinical trials4
Recruiting0
Common conditions1
Lead sponsors shown1

Clinical trials

4 shown
A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric AsthmaticsNCT02126839 · 2014-05-01
COMPLETED
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent AsthmaNCT01424813 · 2012-12-01
COMPLETED
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State PharmacokineticsNCT01747629 · 2012-12-01
COMPLETED
Safety Study of Albuterol Spiromax® in Subjects With AsthmaNCT01698320 · 2012-10-01
COMPLETED

Trial status mix

COMPLETED4

Phase mix

PHASE34

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.